435 related articles for article (PubMed ID: 27288651)
1. Challenges and strategies for the eradication of the HIV reservoir.
Kimata JT; Rice AP; Wang J
Curr Opin Immunol; 2016 Oct; 42():65-70. PubMed ID: 27288651
[TBL] [Abstract][Full Text] [Related]
2. The forces driving clonal expansion of the HIV-1 latent reservoir.
Liu R; Simonetti FR; Ho YC
Virol J; 2020 Jan; 17(1):4. PubMed ID: 31910871
[TBL] [Abstract][Full Text] [Related]
3. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.
Pierson T; McArthur J; Siliciano RF
Annu Rev Immunol; 2000; 18():665-708. PubMed ID: 10837072
[TBL] [Abstract][Full Text] [Related]
4. Measuring replication competent HIV-1: advances and challenges in defining the latent reservoir.
Wang Z; Simonetti FR; Siliciano RF; Laird GM
Retrovirology; 2018 Feb; 15(1):21. PubMed ID: 29433524
[TBL] [Abstract][Full Text] [Related]
5. The role of integration and clonal expansion in HIV infection: live long and prosper.
Anderson EM; Maldarelli F
Retrovirology; 2018 Oct; 15(1):71. PubMed ID: 30352600
[TBL] [Abstract][Full Text] [Related]
6. HAART-persistent HIV-1 latent reservoirs: their origin, mechanisms of stability and potential strategies for eradication.
Kulkosky J; Bray S
Curr HIV Res; 2006 Apr; 4(2):199-208. PubMed ID: 16611058
[TBL] [Abstract][Full Text] [Related]
7. Regulation of human immunodeficiency virus-1 latency and its reactivation.
Verdin E
Bull Mem Acad R Med Belg; 2008; 163(6):355-64; discussion 364-5. PubMed ID: 19445107
[TBL] [Abstract][Full Text] [Related]
8. Latency: the hidden HIV-1 challenge.
Marcello A
Retrovirology; 2006 Jan; 3():7. PubMed ID: 16412247
[TBL] [Abstract][Full Text] [Related]
9. Low-level HIV-1 replication and the dynamics of the resting CD4+ T cell reservoir for HIV-1 in the setting of HAART.
Sedaghat AR; Siliciano RF; Wilke CO
BMC Infect Dis; 2008 Jan; 8():2. PubMed ID: 18171475
[TBL] [Abstract][Full Text] [Related]
10. Suppression of HIV replication in the resting CD4+ T cell reservoir by autologous CD8+ T cells: implications for the development of therapeutic strategies.
Chun TW; Justement JS; Moir S; Hallahan CW; Ehler LA; Liu S; McLaughlin M; Dybul M; Mican JM; Fauci AS
Proc Natl Acad Sci U S A; 2001 Jan; 98(1):253-8. PubMed ID: 11136258
[TBL] [Abstract][Full Text] [Related]
11. A stable latent reservoir for HIV-1 in resting CD4(+) T lymphocytes in infected children.
Persaud D; Pierson T; Ruff C; Finzi D; Chadwick KR; Margolick JB; Ruff A; Hutton N; Ray S; Siliciano RF
J Clin Invest; 2000 Apr; 105(7):995-1003. PubMed ID: 10749578
[TBL] [Abstract][Full Text] [Related]
12. Stable Phenotypic Changes of the Host T Cells Are Essential to the Long-Term Stability of Latent HIV-1 Infection.
Seu L; Sabbaj S; Duverger A; Wagner F; Anderson JC; Davies E; Wolschendorf F; Willey CD; Saag MS; Goepfert P; Kutsch O
J Virol; 2015 Jul; 89(13):6656-72. PubMed ID: 25878110
[TBL] [Abstract][Full Text] [Related]
13. A reservoir for HIV in patients on combination antiretroviral therapy.
Siliciano RF
Hopkins HIV Rep; 1998 Jan; 10(1):1, 5-6, 11. PubMed ID: 11365130
[TBL] [Abstract][Full Text] [Related]
14. Peering into the HIV reservoir.
García M; Buzón MJ; Benito JM; Rallón N
Rev Med Virol; 2018 Jul; 28(4):e1981. PubMed ID: 29744964
[TBL] [Abstract][Full Text] [Related]
15. Targeting HIV latency: resting memory T cells, hematopoietic progenitor cells and future directions.
Sebastian NT; Collins KL
Expert Rev Anti Infect Ther; 2014 Oct; 12(10):1187-201. PubMed ID: 25189526
[TBL] [Abstract][Full Text] [Related]
16. Limits on replenishment of the resting CD4+ T cell reservoir for HIV in patients on HAART.
Sedaghat AR; Siliciano JD; Brennan TP; Wilke CO; Siliciano RF
PLoS Pathog; 2007 Aug; 3(8):e122. PubMed ID: 17784786
[TBL] [Abstract][Full Text] [Related]
17. Viral latency and potential eradication of HIV-1.
Matreyek KA; Oztop I; Freed EO; Engelman A
Expert Rev Anti Infect Ther; 2012 Aug; 10(8):855-7. PubMed ID: 23030323
[TBL] [Abstract][Full Text] [Related]
18. The challenge of viral reservoirs in HIV-1 infection.
Blankson JN; Persaud D; Siliciano RF
Annu Rev Med; 2002; 53():557-93. PubMed ID: 11818490
[TBL] [Abstract][Full Text] [Related]
19. Improved assays to measure and characterize the inducible HIV reservoir.
Massanella M; Yek C; Lada SM; Nakazawa M; Shefa N; Huang K; Richman DD
EBioMedicine; 2018 Oct; 36():113-121. PubMed ID: 30316868
[TBL] [Abstract][Full Text] [Related]
20. Latently infected cell activation: a way to reduce the size of the HIV reservoir?
Forde J; Volpe JM; Ciupe SM
Bull Math Biol; 2012 Jul; 74(7):1651-72. PubMed ID: 22562387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]